Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.
Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...
Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.
The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.
8d
GlobalData on MSNAbbott accelerates PFA market competition in Europe with early Volt approvalThough late to the party compared to other industry leaders, Abbott joins a pulsed field ablation market poised for ...
Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...
Explore more
8d
Zacks.com on MSNInternational Expansion, Product Launches Support BSX StockBoston Scientific continues to successfully expand its operations across various geographies outside the United States.
Tesla, The Home Depot, Boston Scientific, Frequency Electronics and Bridger Aerospace are included in this Analyst Blog.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results